t type calcium channel 399 enhancers (TargetMol)
TargetMol is a verified supplier 
TargetMol manufactures this product 
94
Structured Review
TargetMol
t type calcium channel 399 enhancers
T Type Calcium Channel 399 Enhancers, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/system+coupling+module/Calcium+Channel+Compound+Library/pm41874002-169-12-21
Average 94 stars, based on 3 article reviews
T Type Calcium Channel 399 Enhancers, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/system+coupling+module/Calcium+Channel+Compound+Library/pm41874002-169-12-21
Average 94 stars, based on 3 article reviews
t type calcium channel 399 enhancers - by Bioz Stars,
2026-11
94/100 stars
Images
Related Articles
Proliferation Assay:Article Title: Repurposing T-type calcium channel blocker Lomerizine as a therapeutic strategy for glioblastoma. Article Snippet: .. Furthermore, we 398 performed a cell proliferation assay with pretreatment using two Activity Assay:Article Title: Repurposing T-type calcium channel blocker Lomerizine as a therapeutic strategy for glioblastoma. Article Snippet: .. Furthermore, we 398 performed a cell proliferation assay with pretreatment using two Concentration Assay:Article Title: Repurposing T-type calcium channel blocker Lomerizine as a therapeutic strategy for glioblastoma. Article Snippet: .. Furthermore, we 398 performed a cell proliferation assay with pretreatment using two Article Title: RCN3 functions as a tumor promoter in colorectal cancer by modulating the GRP78-PI3K-AKT signaling pathway. Article Snippet: Colorectal cancer (CRC) remains a significant global health concern, highlighting the urgent need for novel therapeutic targets and prognostic biomarkers.. This study investigates the role of Reticulocalbin-3 (RCN3) in CRC development, focusing on its regulatory influence on calcium ion homeostasis and transport proteins, critical factors in cancer progression.. We employed bioinformatics databases, qRT-PCR, Western blotting, and immunohistochemistry to evaluate RCN3 expression levels, revealing that RCN3 is upregulated in CRC tissues and correlates with poorer patient outcomes. High Throughput Screening Assay:Article Title: Sappanchalcone suppresses NSCLC by oxidative stress-driven DNA damage and ER stress activation through PIEZO1 modulation Article Snippet: .. In this study, Drug discovery:Article Title: Sappanchalcone suppresses NSCLC by oxidative stress-driven DNA damage and ER stress activation through PIEZO1 modulation Article Snippet: .. In this study, Fluorescence:Article Title: Sappanchalcone suppresses NSCLC by oxidative stress-driven DNA damage and ER stress activation through PIEZO1 modulation Article Snippet: .. In this study, Incubation:Article Title: RCN3 functions as a tumor promoter in colorectal cancer by modulating the GRP78-PI3K-AKT signaling pathway. Article Snippet: Colorectal cancer (CRC) remains a significant global health concern, highlighting the urgent need for novel therapeutic targets and prognostic biomarkers.. This study investigates the role of Reticulocalbin-3 (RCN3) in CRC development, focusing on its regulatory influence on calcium ion homeostasis and transport proteins, critical factors in cancer progression.. We employed bioinformatics databases, qRT-PCR, Western blotting, and immunohistochemistry to evaluate RCN3 expression levels, revealing that RCN3 is upregulated in CRC tissues and correlates with poorer patient outcomes. |